http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104684904-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ef2e9f5ce8630d9b282043b8d060caff
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C2601-08
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-381
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-38
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-381
filingDate 2013-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef0e584e92d58455100a06c069f66a28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98bbe6c7d29b0b06966ef7c7531c05c9
publicationDate 2015-06-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104684904-A
titleOfInvention Attenuation of central corneal thickening by use of a hydrophilic ester prodrug of β-chlorocyclopentane
abstract The present invention provides compositions and methods for treating glaucoma. Specifically, the present invention provides hydrophilic ester prodrugs of formula (I) and formula (III) and said compounds for reducing central corneal thickening, wherein L1-L3, R1 and R2 are as claimed in claim 1 and n and R2D are as defined in claim 37.
priorityDate 2012-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102007098-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008008718-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010210689-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009270396-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467820580
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73332833
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID428529178

Total number of triples: 24.